Re Joint Venture

Advanced Medical Solutions Grp PLC
8 May 2002


For Immediate Release:                                   Wednesday, 8 May 2002


          Advanced Medical Solutions Group plc ('AMS' or the Company)
                 Announces Collaboration with Johnson & Johnson
                 Wound Management - a Division of ETHICON, Inc.


Winsford, UK: AMS, the tissue repair company, has today announced a global
collaboration with Johnson & Johnson Wound Management, a Division of ETHICON,
Inc., to supply a range of patented calcium alginate based products, for initial
launch into the North American market.

The alginate advanced woundcare dressings will be marketed by Johnson & Johnson
Wound Management under the NU-DERM* Alginate Wound Dressing brand and will be
launched into the professional healthcare market in the United States in May
2002.

Commenting on the collaboration Dr Don Evans, Chief Executive Officer of AMS,
said:

'We are delighted to have entered into a partnership with such a strong global
player as Johnson & Johnson Wound Management. They are one of the world's
leading wound management companies and certainly one of the most innovative with
a strong commitment to meeting the needs of patients and clinicians. This
collaboration underlines our strategy of partnering with blue-chip companies and
our continued commitment to launching products based on our proprietary
technology into major international markets.'

Robert Salerno, Worldwide President of Johnson & Johnson Wound Management,
stated:

'We are committed to launching innovative new products under strong brands and
this collaboration enables us to bring further enhanced value products into our
range.'



                                    - ENDS -



For further information, please contact:


Advanced Medical Solutions Group plc                        Tel: [phone]
Don Evans, Chief Executive
Graeme Brookes, Sales & Marketing Director
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                             Tel: [phone]
Nicola How                                              Mobile: [phone]



Notes to Editors:


Advanced Medical Solutions is a leading global company in the development and
manufacture of products for the £4 billion global advanced woundcare and wound
closure market.

Founded in 1991 and currently listed on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The recent acquisition of MedLogic has brought AMS products and technology in
cyanoacrylate based tissue adhesive sold direct to A & E departments or through
distributors.

AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Coloplast, Smith + Nephew and Beiersdorf.



                      This information is provided by RNS
            The company news service from the London Stock Exchange